California · 81335

Gene Analysis (thiopurine S-Methyltransferase) For Common Variant in California

California Medicare Avg
$159.89
7% below national avg
National Medicare Avg
$171.14
All states combined
Billed Charge (CA)
$437.04
What providers submit
Est. Commercial (CA)
$383.73
National avg: $383.35
Est. Cash / Self-Pay (CA)
$240.10
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

15
Services in CA
4
Providers
N/A
Min Payment
N/A
Max Payment

California Pricing in Context

In California, CPT code 81335 (Gene Analysis (thiopurine S-Methyltransferase) For Common Variant) carries an average Medicare payment of $159.89 — 7% below the national benchmark of $171.14. 4 providers across the state submitted claims for this procedure in 2023, performing 15 total services. Individual payments in CA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in California is $437.04, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because California sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Urinalysis procedures, the estimated commercial insurance price in California lands near $383.73, with self-pay cash prices typically around $240.10. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Gene Analysis (thiopurine S-Methyltransferase) For Common Variant cost in California?

The average Medicare payment for Gene Analysis (thiopurine S-Methyltransferase) For Common Variant in California is $159.89, which is 7% below the national average of $171.14. Providers in CA typically bill $437.04 for this procedure.

What does Gene Analysis (thiopurine S-Methyltransferase) For Common Variant cost with insurance in California?

With commercial insurance in California, Gene Analysis (thiopurine S-Methyltransferase) For Common Variant costs an estimated $383.73. Without insurance, the estimated cash price is $240.10. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Gene Analysis (thiopurine S-Methyltransferase) For Common Variant in California?

4 providers in California billed Medicare for Gene Analysis (thiopurine S-Methyltransferase) For Common Variant in 2023, performing 15 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Gene Analysis (thiopurine S-Methyltransferase) For Common Variant cheaper in California than the national average?

Yes — Gene Analysis (thiopurine S-Methyltransferase) For Common Variant costs 7% below the national average in California. The state average Medicare payment is $159.89 compared to $171.14 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial